饶毅回应：我为何向刘革新开炮

Core Viewpoint - The article discusses the controversy surrounding the health product ergothioneine, with prominent biologist Rao Yi criticizing its promotion by Kelun Pharmaceutical, while Kelun defends its scientific validity and market positioning [2][3][4][8]. Group 1: Criticism of Ergothioneine - Rao Yi labels ergothioneine as a "fake drug" due to its lack of approval as a medicine, arguing that products without sufficient evidence should not be marketed as effective [4][5][6]. - Rao Yi expresses a general skepticism towards health supplements, stating that most promoted in China are misleading and detrimental to social ethics [11]. - Rao Yi criticizes the marketing tactics of Kelun's chairman, Liu Gexin, who used his physique to promote ergothioneine, suggesting it misleads the public into believing the product can deliver similar results [16][17]. Group 2: Kelun Pharmaceutical's Response - Kelun Pharmaceutical responds to Rao Yi's criticisms by emphasizing the scientific basis and safety of ergothioneine, citing its applications in various health domains such as sleep, cognition, skin aging, and cardiovascular health [7][13]. - The company outlines four key arguments in defense of ergothioneine: scientific validation, global regulatory backing, commitment to preventive medicine, and the promotion of industry standardization [7]. - Kelun highlights that ergothioneine has been recognized as a novel food supplement in developed regions, supported by clinical research published in top-tier journals [7][8].